Fingerprint
Dive into the research topics of 'Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically